Exagen Registers $150M Shelf, Including $50M TD Securities ATM
XGN has more than doubled off its 52-week low of $2.59.
Summary
Exagen registered a $150 million aggregate shelf and signed a sales agreement with TD Securities to sell up to $50 million of common stock through an at-the-market program. The shelf is large next to the company's roughly $127 million market cap, and the ATM alone could add meaningfully to the share count. This lands the same day as the Q3 report, which showed revenue up 7% to $18.4M but cash down to $28.1M alongside a $5.0M debt draw — the company is lining up equity capacity while burning cash. The stock closed at $5.26, below the $5.81 level referenced when the shelf was registered, so any sales at current prices would be more dilutive than that initial math implied. Watch for 424B prospectus supplements disclosing actual share sales under the ATM.
At the time of this announcement, XGN was trading at $5.26 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $127.4M. The 52-week trading range was $2.59 to $10.27. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.